Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Bristol Myers Squibb (BMYMP) over the last 16 years, with Q4 2025 value amounting to $396.0 million.

  • Bristol Myers Squibb's Long-Term Investments rose 2375.0% to $396.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $396.0 million, marking a year-over-year increase of 2375.0%. This contributed to the annual value of $396.0 million for FY2025, which is 2375.0% up from last year.
  • Bristol Myers Squibb's Long-Term Investments amounted to $396.0 million in Q4 2025, which was up 2375.0% from $406.0 million recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Long-Term Investments registered a high of $406.0 million during Q3 2025, and its lowest value of $46.0 million during Q3 2021.
  • For the 4-year period, Bristol Myers Squibb's Long-Term Investments averaged around $308.4 million, with its median value being $345.0 million (2025).
  • Per our database at Business Quant, Bristol Myers Squibb's Long-Term Investments plummeted by 9070.71% in 2021 and then surged by 2530.86% in 2025.
  • Bristol Myers Squibb's Long-Term Investments (Quarter) stood at $46.0 million in 2021, then surged by 691.3% to $364.0 million in 2023, then fell by 12.09% to $320.0 million in 2024, then increased by 23.75% to $396.0 million in 2025.
  • Its Long-Term Investments was $396.0 million in Q4 2025, compared to $406.0 million in Q3 2025 and $346.0 million in Q2 2025.